Table 5. Potential Contraindications by Type of Prescription Provider.
| Variable | No. (%) | P value | ||
|---|---|---|---|---|
| Clinician (n = 266) | Pharmacist (n = 144) | Total (n = 410) | ||
| Potential contraindication with estrogen | ||||
| High blood pressure | 7 (2.6) | 5 (3.5) | 12 (2.9) | .46a |
| History of blood clots | 2 (0.8) | 0 | 2 (0.5) | .54a |
| Migraines with auras | 32 (12.0) | 15 (10.4) | 47 (11.5) | .62 |
| Current smoker and age >35 y | 1 (0.4) | 1 (0.7) | 2 (0.5) | >.99 |
| Multiple risk factors for atherosclerotic cardiovascular diseaseb | 2 (0.8) | 4 (2.8) | 6 (1.5) | .19a |
| Women with a potential contraindicationc | 40 (15.0) | 20 (13.9) | 60 (14.6) | .75 |
| Among women with a potential contraindication (n = 60)c | ||||
| Prescribed a method containing estrogen | 32 (80.0) | 14 (70.0) | 43 (71.7) | .52a |
| Prescribed a progestin-only method | 8 (20.0) | 6 (30.0) | 14 (23.3) | |
a
P value based on Fisher method on 2 × 2 cross tabulation (Fisher exact test).
b
Defined as being of age ≥40 y and either being a current smoker or having high blood pressure.
c
Defined as having high blood pressure, a history of blood clots, or migraines with auras; being a current smoker >35 y of age; or having multiple risk factors for atherosclerotic cardiovascular disease.